Gemin X Pharmaceuticals, Inc.: Series E $8M

Posted in I - Series E, Q - 3Q10, R - NORTH EAST, X - Oncology, XX - PA

Gemin X Pharmaceuticals (Malvern, PA) a clinical-stage biopharmaceutical company focused on chronic lymphocytic leukemia, melanoma, small cell lung cancer, lymphoma, myeloma and glioblastoma multiforme, closed a $8M Series E financing. Participants include Caxton Advantage Life Sciences Fund and Sanderling Ventures.

Aug

2010

Health Market Science, Inc.: Series B $6.1M

Posted in I - Series B, Q - 3Q10, R - NORTH EAST, X - TeleMedicine, XX - PA

Health Market Science (King of Prussia, PA) a commercial-stage biopharma and healthcare data and analytics provider, closed a $6.1M Series B financing. Participants include Cross Atlantic Capital Partners and Edison Venture Fund.

Aug

2010

TetraLogic Pharmaceuticals, Inc.: Series C $32M

Posted in I - Series C, Q - 3Q10, R - NORTH EAST, X - Apoptosis, X - Necrosis, XX - PA

TetraLogic Pharmaceuticals (Malvern, PA) a preclinical-stage small molecule company focused on apoptosis and necrosis modulation for potential cancer, cardiovascular, neurological and ophthalmic disease treatment, closed a $32M Series C financing. Participants include Clarus Ventures, Hatteras Venture Partners, Amgen Ventures, HealthCare Ventures, Latterell Venture Partners, Novitas Capital, Quaker BioVentures and Vertical Group.

Aug

2010

Trevena, Inc.: Series B $35M

Posted in I - Series B, Q - 3Q10, R - NORTH EAST, X - Cardiology, X - G-Protein, X - Pain, XX - PA

Trevena (Berwyn, PA) a clinical-stage small molecule company focused on G-protein coupled receptor targeting for heart failure and pain, closed a $35M Series B funding from existing investors. Participants include Polaris Venture Partners, New Enterprise Associates, Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company.

Jul

2010

Molecular Detection, Inc.: Series C $1.4M

Posted in I - Series C, Q - 2Q10, R - NORTH EAST, X - Device (Diagnostic), X - MRSA, XX - PA

Molecular Detection (Wayne, PA) a commercial-stage molecular diagnostics company focused on MRSA detection, closed a $1.4M Series C financing, bringing the total round to $4.7M. Participants include MentorTech Ventures.

Mar

2010

Promedior, Inc.: Series C $12M

Posted in I - Series C, Q - 1Q10, R - NORTH EAST, X - Fibrosis, X - Inflammation, XX - PA

Promedior (Malvern, PA) a clinical-stage biopharmaceutical company focused on inflammation and fibrotic disease, closed a $12M Series C financing. Participants include Forbion Capital Partners, Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners and Easton Capital.

Mar

2010

Saladax Biomedical, Inc.: Series C $8.4M

Posted in I - Series C, Q - 1Q10, R - NORTH EAST, X - 5-FU, X - Device (Diagnostic), XX - PA

Saladax Biomedical (Bethlehem, PA) a commercial stage developer of 5-FU diagnostic assays for the oncology market, closed an $8.4M Series B financing. Participants include Excel Venture Management, Golden Seeds, Ben Franklin Technology Partners and Life Sciences Greenhouse of Central Pennsylvania.

Jan

2010

MobileMD, Inc.: Series A $4.7M

Posted in I - Series A, Q - 4Q09, R - NORTH EAST, X - TeleMedicine, XX - PA

MobileMD (Warminster, PA) a commercial-stage electronic medical records information exchange and clinical data repository platform, closed a $4.7M Series A financing. Participants include Health Enterprise Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Dec

2009

Molecular Detection, Inc.: Series C $3.3M

Posted in I - Series C, Q - 4Q09, R - NORTH EAST, X - Device (Diagnostic), X - MRSA, XX - PA

Molecular Detection (Wayne, PA) a development-stage molecular diagnostics company focused on reat-time PCR of MRSA detection, closed a $3.3M Series C financing. Participants include MentorTech Ventures, Ben Franklin Technology Partners, Robin Hood Ventures and the Mid-Atlantic Angel Group.

Dec

2009

ThermalTherapeutic Systems, Inc.: Series A $2.7M

Posted in I - Series A, Q - 4Q09, R - NORTH EAST, X - Device (Perfusion), XX - PA

ThermalTherapeutic Systems (Pittsburgh, PA) a development stage device company focused on portable hyperthermic perfusion system for temperature control of the thoracic or peritoneal cavity, closed a $2.7M Serie A financing. Participants include Originate Ventures, Pittsburgh Life Sciences Greenhouse and Innovation Works.

« Previous Entries

to top of page...